New appointments at Synovate Healthcare
26 February 2004
LONDON — SYNOVATE Healthcare, a specialist research division of global research company Synovate, has announced key management appointments effective 1st April 2004. Changes in the management structure draw from the strengths of Isis Research, which was acquired by Synovate in September last year, and Synovate's existing healthcare practice. Isis will rebrand as Synovate Healthcare in October 2004.
Marc Yates has been named Regional Director Synovate Healthcare Asia Pacific. Yates joined Isis Research in 1996, and has been employed in market research for nearly 20 years, gaining wide experience of techniques and methodologies including retail and OTC. After starting with Isis in the London head office, he moved to Shanghai in 1998 to set up a representative office. He then moved to Hong Kong after 18 months to take on a regional role overseeing pan-Asian studies. Three years later he moved to Singapore where he established Isis' South Asia regional office. Yates will continue to be based in Singapore.
Stuart Bartlett has been appointed Director Synovate Healthcare Asia Pacific. A graduate of Isis Research in London, Bartlett spent four years specialising in sales force effectiveness and ad-hoc research. He moved to Hong Kong in 2001 to head up the Isis representative office; two years later he joined Synovate as director of the healthcare division. He is currently based in Singapore.
Robert Skolnick has been named Executive Vice President Synovate Healthcare US Custom. Skolnick will continue in his existing role as Executive Vice President of Synovate Americas, responsible for the company's specialist research units as well as its corporate development programmes. Skolnick is based in Tarrytown, New York.
Commenting on the changes, Michael Spedding, CEO Synovate Healthcare, said: "The integration of Isis and Synovate Healthcare is an exciting phase in the development of Synovate Healthcare. These key appointments are an important step in developing the foundation for the continued success of Synovate Healthcare which is one of Synovate's key specialist divisions."
Contact(s) for this press release
|
Alicia Kan
Global Head of Communications |
|
Telephone: +1 312 526 4570 |
Synovate Healthcare is the global specialist healthcare market research arm of Synovate, dedicated to delivering marketing insights to the pharmaceutical and healthcare industries. Synovate Healthcare employs over 500 healthcare market research professionals across Europe, US, Canada, Asia Pacific and Japan and offers syndicated and custom research as well as global fieldwork capabilities.
More information on Synovate Healthcare can be found at www.synovate.com/healthcare.
About Synovate
Synovate generates insights to help clients drive competitive brand, product and customer experience strategies. Now part of Ipsos, with offices in over 80 countries, our approach combines best in class global research capabilities with personalised service, local knowledge and the flexibility to create teams and processes that meet clients' specific requirements. At Synovate, our clients sit at the top of our organisational chart, driving us to continually develop more innovative research solutions that predict actual business outcomes.
For more information on Synovate visit www.synovate.com.
